Jingqiao Qiao

1098 Xueyuan Ave
Shenzhen, 518060, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications

Clinical outcomes and spatial transcriptomic profiles of CD19/20 CAR-T therapy in relapsed or refractory B-cell non-Hodgkin's lymphoma.

Clinical outcomes and spatial transcriptomic profiles of CD19/20 CAR-T therapy in relapsed or refractory B-cell non-Hodgkin's lymphoma.

Journal: Journal for immunotherapy of cancer
Published: May 05, 2026

Acute Myeloid Leukemia With NPM1 Mutation Post Cytotoxic Therapy Mimicking CEL, NOS.

Acute Myeloid Leukemia With NPM1 Mutation Post Cytotoxic Therapy Mimicking CEL, NOS.

Journal: International journal of laboratory hematology
Published: November 25, 2025

Integrated clinical and single-cell profiling of BCMA CAR-T therapy in relapsed/refractory multiple myeloma.

Integrated clinical and single-cell profiling of BCMA CAR-T therapy in relapsed/refractory multiple myeloma.

Journal: Journal of translational medicine
Published: July 02, 2025

Anti-CD19 CAR-T cell therapy in relapsed/refractory t(8;21) acute myeloid leukemia with aberrant CD19 expression.

Anti-CD19 CAR-T cell therapy in relapsed/refractory t(8;21) acute myeloid leukemia with aberrant CD19 expression.

Journal: Frontiers in immunology
Published: April 24, 2025

CLDN18.2-targeting STAR-T cell therapy for pancreatic cancer: a strategy to minimize gastric off-tumor toxicity compared to CLDN18.2 CAR-T.

CLDN18.2-targeting STAR-T cell therapy for pancreatic cancer: a strategy to minimize gastric off-tumor toxicity compared to CLDN18.2 CAR-T.

Journal: Oncogene
Published: November 07, 2024

Loss of SETD8 Impairs Mitochondrial Homeostasis to Suppress Leukemia Stem Cell Function in t(8;21) Acute Myeloid Leukemia.

Loss of SETD8 Impairs Mitochondrial Homeostasis to Suppress Leukemia Stem Cell Function in t(8;21) Acute Myeloid Leukemia.

Journal: Cancer research
Published: October 04, 2024

Bispecific CAR-T cells targeting CD19/20 in patients with relapsed or refractory B cell non-Hodgkin lymphoma: a phase I/II trial.

Bispecific CAR-T cells targeting CD19/20 in patients with relapsed or refractory B cell non-Hodgkin lymphoma: a phase I/II trial.

Journal: Blood cancer journal
Published: March 17, 2024

Favorable response of a patient with primary B/myeloid mixed phenotype acute Leukemia to CD19-CAR-T: Case report and literature review.

Favorable response of a patient with primary B/myeloid mixed phenotype acute Leukemia to CD19-CAR-T: Case report and literature review.

Journal: Medicine
Published: December 20, 2023

Complete remission of advanced pancreatic cancer induced by claudin18.2-targeted CAR-T cell therapy: a case report.

Complete remission of advanced pancreatic cancer induced by claudin18.2-targeted CAR-T cell therapy: a case report.

Journal: Frontiers in immunology
Published: October 22, 2023

A novel immune-related gene signature predicts the prognosis of hepatocellular carcinoma.

A novel immune-related gene signature predicts the prognosis of hepatocellular carcinoma.

Journal: Frontiers in oncology
Published: July 01, 2022

Antigen-Specific TCR-T Cells for Acute Myeloid Leukemia: State of the Art and Challenges.

Antigen-Specific TCR-T Cells for Acute Myeloid Leukemia: State of the Art and Challenges.

Journal: Frontiers in oncology
Published: September 30, 2021

The role of ARHGAP9: clinical implication and potential function in acute myeloid leukemia.

The role of ARHGAP9: clinical implication and potential function in acute myeloid leukemia.

Journal: Journal of translational medicine
Published: December 14, 2020
Showing 1-12 of 12

Last Updated: 09/26/2026